Track topics on Twitter Track topics that are important to you
Proscia has inked a deal with a dermatopathology laboratory in a move designed to support its launch of a comprehensive AI-powered digital pathology softwaredermatopathology-specific digital patholo...
Landmark agreement positions Proscia to transform dermatopathology market − and opens doors to additional lab partnerships Proscia Inc., creators of AI-powe...
Appropriate use criteria (AUC) provide physicians guidance in test selection, can affect health care delivery, reimbursement policy, and physician decision-making.
The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole genome, whol...
Founded by Texas physicians, Azam Anwar, M.D., and highly regarded dermatopathologist Clay Cockerell, M.D., TopMD Skin Care released its premier product, CLnÂ® BodyWash, in the ...
The company's extensive diagnostics infrastructure includes over 400 pathologists and doctorate-level scientists providing services in over 40 independent pathology laboratories, more than 200 hospita...
GPA stands for Greensboro Pathology Associates, P.A., but don't let the name fool you, we're not just in Greensboro. We can provide services anywhere. GPA is a privately owned independent pathology pr...
Caris Diagnostics (Caris Dx) is a leading provider of the highest quality diagnostic, translational development and pharmaceutical services encompassing anatomic pathology and molecular testing. C...
We have published hundreds of Cockerell Dermatopathology news stories on BioPortfolio along with dozens of Cockerell Dermatopathology Clinical Trials and PubMed Articles about Cockerell Dermatopathology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cockerell Dermatopathology Companies in our database. You can also find out about relevant Cockerell Dermatopathology Drugs and Medications on this site too.